According to Glenmark Pharmaceuticals 's latest financial reports the company's current earnings (TTM) are $94.84 M. In 2023 the company made an earning of -$61.23 M a decrease over its 2022 earnings that were of $0.20 B.The earnings displayed on this page is the company's Pretax Income.